Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion

Transfusion

Volumn 53, Issue 6, 2013, Pages 1319-1327

  Liepkalns, Justine S ^a   Cadwell, Chantel M ^a   Stowell, Sean R ^a   Hod, Eldad A ^a   Spitalnik, Steven L ^a   Zimring, James C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; GLYCOPHORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY MEDIATED REJECTION; ARTICLE; BLOOD DONOR; BLOOD GROUP INCOMPATIBILITY; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNIZATION; MOUSE; NONHUMAN; PHAGOCYTE; PLASMA CLEARANCE; RECIPIENT; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, HETEROPHILE; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CELL SURVIVAL; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FEMALE; GLYCOPHORIN; HUMANS; ISOANTIBODIES; ISOANTIGENS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHAGOCYTOSIS;

EID: 84878911512     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03910.x     Document Type: Article

References (27)

1. Blumberg N, Peck K, Ross K, Avila E,. Immune response to chronic red blood cell transfusion. Vox Sang 1983; 44: 212-217.
2. Heddle NM, Soutar RL, O'Hoski PL, Singer J, McBride JA, Ali MA, Kelton JG,. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995; 91: 1000-1005.
3. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA,. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995; 119: 42-45.
4. Reid M, Lomas-Francis C,. The blood group antigen facts book. 2nd ed. Amsterdam: Elsevier Academic Press; 2004.
5. Daniels G,. Human blood groups. 2nd ed. Oxford: Blackwell Science; 2002.
6. Zimring JC, Spitalnik SL,. Alloimmunization to red cell antigens and management of alloimmunized patients. In:, Mintz PD, editor. Transfusion therapy clinical principles and practice. Bethesda (MD): American Association of Blood Banks; 2011. p. 631-642.
7. Janatpour KA, Kalmin ND, Jensen HM, Holland PV,. Clinical outcomes of ABO-incompatible RBC transfusions. Am J Clin Pathol 2008; 129: 276-281.
8. Klein HG, Anstee DJ,. Blood transfusion in clinical medicine. Malden (MA): Blackwell Publishing; 2005.
9. Auffray I, Marfatia S, de Jong K, Lee G, Huang CH, Paszty C, Tanner MJ, Mohandas N, Chasis JA,. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood 2001; 97: 2872-2878.
10. Bigbee WL, Langlois RG, Vanderlaan M, Jensen RH,. Binding specificities of eight monoclonal antibodies to human glycophorin A-studies with McM, and MkEn(UK) variant human erythrocytes and M- and MNV-type chimpanzee erythrocytes. J Immunol 1984; 133: 3149-3155.
11. Bigbee WL, Vanderlaan M, Fong SS, Jensen RH,. Monoclonal antibodies specific for the M- and N-forms of human glycophorin A. Mol Immunol 1983; 20: 1353-1362.
12. Blackall DP, Ugorski M, Pahlsson P, Shakin-Eshleman SH, Spitalnik SL,. A molecular biologic approach to study the fine specificity of antibodies directed to the MN human blood group antigens. J Immunol 1994; 152: 2241-2247.
13. Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, Roback JD,. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005; 106: 1105-1112.
14. Schirmer DA, Song SC, Baliff JP, Harbers SO, Clynes RA, Krop-Watorek A, Halverson GR, Czerwinski M, Spitalnik SL,. Mouse models of IgG- and IgM-mediated hemolysis. Blood 2007; 109: 3099-3107.
15. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC,. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fc gamma receptors in a murine model. Transfusion 2012; 52: 2631-2645.
16. Gros P, Milder FJ, Janssen BJ,. Complement driven by conformational changes. Nat Rev Immunol 2008; 8: 48-58.
17. Beum PV, Kennedy AD, Li Y, Pawluczkowycz AW, Williams ME, Taylor RP,. Complement activation and C3b deposition on rituximab-opsonized cells substantially blocks binding of phycoerythrin-labeled anti-mouse IgG probes to rituximab. J Immunol Methods 2004; 294: 37-42.
18. Moller G,. Antibody-induced depression of the immune response: a study of the mechanism in various immunological systems. Transplantation 1964; 2: 405-415.
19. Moller G,. Isoantibody-induced cellular resistance to immune haemolysis in vivo and in vitro. Nature 1964; 202: 357-359.
20. Freedman J, Semple JW,. Complement in transfusion medicine. In:, Garratty G, editor. Immunobiology of transfusion medicine. New York: Marcel Dekker; 1994. p. 403-434.
21. Atkinson JP, Frank MM,. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest 1974; 54: 339-348.
22. Brown DL, Lachmann PJ, Dacie JV,. The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits. Clin Exp Immunol 1970; 7: 401-421.
23. Jandl JH, Jones AR, Castle WB,. The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest 1957; 36: 1428-1459.
24. Schreiber AD, Frank MM,. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum. J Clin Invest 1972; 51: 583-589.
25. Brain MC, Ruether B, Valentine K, Brown C, ter Keurs H,. Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination. Transfusion 2010; 50: 292-301.
26. Garratty G,. A new mechanism for immune destruction of red blood cells? Transfusion 2010; 50: 274-277.
27. Campbell-Lee SA, Liu J, Velliquette RW, Halverson GR, Shirey RS, Chaudhuri A, Reid ME, Ness PM, Baldwin WM,. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Transfusion 2006; 46: 1682-1688.